Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2007-09-18
2007-09-18
Harris, Alana M. (Department: 1643)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S004000, C435S006120, C435S007210, C435S007230, C435S007920, C435S085000, C435S087000, C435S089000, C435S091100, C435S091500, C435S091510, C436S063000, C436S064000, C436S174000, C536S001110, C536S018700, C536S022100, C536S023100
Reexamination Certificate
active
09232880
ABSTRACT:
Compounds and methods for diagnosing prostate cancer are provided. The inventive compounds include polypeptides containing at least a portion of a prostate tumor protein. The inventive polypeptides may be used to generate antibodies useful for the diagnosis and monitoring of prostate cancer. Nucleic acid sequences for preparing probes, primers, and polypeptides are also provided.
REFERENCES:
patent: 5786148 (1998-07-01), Bandman et al.
patent: 652 014 (1995-05-01), None
patent: WO93/14755 (1993-08-01), None
patent: WO93/25224 (1993-12-01), None
patent: WO94/09820 (1994-05-01), None
patent: WO95/04548 (1995-02-01), None
patent: WO95/30758 (1995-11-01), None
patent: WO96/21671 (1996-07-01), None
patent: WO98/37093 (1998-08-01), None
patent: WO98/37418 (1998-08-01), None
patent: WO98/45420 (1998-10-01), None
Nucleic acid database, Accession #V58522, 1998.
Nucleic acid database, Accession #V61287, 1999.
Tockman et al. Considerations in Bringing a Cancer Biomarker to Clinical Application. Cancer Research (Suppl.) 52:2711s-2718s, May 1, 1992.
Tascilar et al. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Annals of Oncology 10,Suppl. 4:S107-S110, 1999).
Nucleic acid database, Accession #V62429, 1998.
Alexeyev et al., “Improved antibiotic-resistance gene cassettes and omega elements forEscherichia colivector construction and in vitro deletion/insertion mutagenesis,”Gene 160: 63-67, 1995.
Blok et al., “Isolation of cDNAs That Are Differentially Expressed Between Androgen-Dependent and Androgen-Independent Prostate Carcinoma Cells Using Differential Display PCR,”The Prostate 26: 213-224, 1995.
Database EMBL Accession No. AA453562, Jun. 11, 1997, Hillier et al., “Homo Sapiens cDNA Clone 788180.”
El-Shirbiny, Prostatic Specific Antigen,Advances In Clinical Chemistry 31: 99-133, 1994.
Robson et al., “Identification of prostatic androgen regulated genes using the differential display technique,”Proceedings Of The American Association For Cancer Research Meeting 86, 36: p. 266, Abstract No. 1589, 1995.
Short et al., “λ ZAP: a bacteriophage λ expression vector within vivoexcision properties,”Nucleic Acids Research 16(15): 7583-7600, 1988.
Dillon Davin C.
Mitcham Jennifer Lynn
Xu Jiangchun
Corixa Corporation
Harris Alana M.
Seed IP Law Group PLLC
LandOfFree
Compounds for immunodiagnosis of prostate cancer and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for immunodiagnosis of prostate cancer and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for immunodiagnosis of prostate cancer and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3743447